Genix Pharmaceuticals (TSXV:GENX) ROCE % : 0.00% (As of Jan. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Genix Pharmaceuticals ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Genix Pharmaceuticals's annualized ROCE % for the quarter that ended in Jan. 2024 was 0.00%.

Genix Pharmaceuticals ROCE % Historical Data

The historical data trend for Genix Pharmaceuticals's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genix Pharmaceuticals ROCE % Chart

Genix Pharmaceuticals Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

ROCE %

Get a 7-Day Free Trial

-402.47

-28.86

-36.56

-29.43

-421.64

Genix Pharmaceuticals Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
ROCE %	Get a 7-Day Free Trial															-28.39	-31.52	-23.20	-2,088.36	-

Genix Pharmaceuticals ROCE % Calculation

Genix Pharmaceuticals's annualized ROCE % for the fiscal year that ended in Oct. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Oct. 2023 )		(A: Oct. 2022 )		(A: Oct. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Oct. 2023 )		(A: Oct. 2022 )		(A: Oct. 2023 )
	=	-4.345	/	( ( (4.253 - 1.054)	+	(0.223 - 1.361) )	/ 2 )
	=	-4.345	/	( (3.199	+	-1.138)	/ 2 )
	=	-4.345	/	1.0305
	=	-421.64 %

Genix Pharmaceuticals's ROCE % of for the quarter that ended in Jan. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jan. 2024 )		(Q: Oct. 2023 )		(Q: Jan. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jan. 2024 )		(Q: Oct. 2023 )		(Q: Jan. 2024 )
	=	-0.14	/	( ( (0.223 - 1.361)	+	(0.247 - 1.443) )	/ 2 )
	=	-0.14	/	( ( -1.138	+	-1.196 )	/ 2 )
	=	-0.14	/	-1.167
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Jan. 2024) EBIT data.

Genix Pharmaceuticals (TSXV:GENX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Genix Pharmaceuticals ROCE % Related Terms

Thank you for viewing the detailed overview of Genix Pharmaceuticals's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Genix Pharmaceuticals (TSXV:GENX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genix Pharmaceuticals Corp (TSXV:GENX) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

GENPF:USA

Address

1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 1J8

Website

https://www.genixpharm.com

Genix Pharmaceuticals Corp is a Canadian life sciences company. It operates as a formulator, manufacturer, licensor, and marketer of life sciences related products with a focus on nutraceuticals and pharmaceuticals. Some of its products are Renochlor, Sucanon, and Flu-X. The company primarily operates in Canada.

Executives

Sina Pirooz

Director

Genix Pharmaceuticals (TSXV:GENX) Headlines

No Headlines